Glob Health Sci Pract. 2013 Mar 21;1(1):29-34. doi: 10.9745/GHSP-D-12-00053. eCollection 2013 Mar.

Can we stop AIDS with antiretroviral-based treatment as prevention?

Author information

1: Stanford Prevention Research Center, Stanford University , Stanford, CA , USA.
2: Johns Hopkins Bloomberg School of Public Health , Baltimore, MD , USA ; Stellenbosch University, Centre for Infectious Diseases , Cape Town, South Africa.
3: Médecins Sans Frontières , Geneva , Switzerland.

Abstract

Challenges to scaling up treatment as prevention (TasP) of HIV transmission are considerable in the developing-world context and include accessing at-risk populations, human resource shortages, adherence and retention in care, access to newer treatments, measurement of treatment effects, and long-term sustainable funding. Optimism about ending AIDS needs to be tempered by the realities of the logistic challenges of strengthening health systems in countries most affected and by balancing TasP with overall combination prevention approaches.